The U.S. market offers significant growth opportunities in cell and gene therapy (CGT) clinical trials, driven by a favorable regulatory landscape, strong research and development activities, and a rising …

Nov 3, 2023 · The U.S. cell and gene therapy clinical trial services market is expected to reach USD 28.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is …

Market growth of gene therapy is exponential and market growth is accelerating. The increasing number of approvals of gene therapies within North America and Europe are the major reasons for market …

12 hours ago · The cell and gene therapy CRO market presents growth opportunities driven by FDA-approved therapies, over 90 global approvals, and 3,500 trials across 16 therapeutic areas, primarily …

Aug 11, 2022 · The market growth is attributed to the increasing prevalence of cancer coupled with the lack of effective treatment for the disease.

SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- The global cell and gene therapy clinical trials market size is expected to reach USD 45.4 billion by2028, according to a new report by Grand...

The market of cell and gene therapy has witnessed significant growth over the past few years with pharma firms partnering to create effective and accessible therapies for patients.

The region's substantial growth is primarily attributed to the cost-effective manufacturing of cell and gene products due to lower labor and operational costs in several Asian economies

Dec 14, 2023 · Based on the product type, the cell therapy segment accounted for the largest share of 41.6% in 2023. Cell therapy services are vital in advancing regenerative medicine & personalized …

For this report, Grand View Research has segmented the U.S. cell and gene therapy clinical trial services market report on the basis of service, phase, therapeutic areas, and therapy type.